Literature DB >> 8434821

Bioreactor based on suspended particles of immobilized enzyme.

L E Freed1, G V Vunjak-Novakovic, P A Drinker, R Langer.   

Abstract

A bioreactor for blood detoxification was developed in which oscillation-induced secondary flows suspend particles of immobilized enzyme in a reactor operating at clinically useful flowrates. Torsional oscillation of the reactor about its axis created a pair of counterrotating toroidal vortices which were readily observed in flow-visualization studies. Oscillation frequencies were selected to provide spatially uniform particle dispersion, as assessed visually. As a model system, blood deheparinization by reactors containing heparinase immobilized to agarose particles was investigated. Identical deheparinization profiles were observed in the continuous-flow reactor and in independent batch studies, done in well mixed test tubes of blood, demonstrating that the oscillating reactor design minimizes external mass transfer limitations. Identical heparin neutralization profiles and rates were also observed in the first and the second of consecutive heparin neutralization studies (0-2 h and 2-4 h, respectively) demonstrating an effective half-life of the immobilized enzyme in the oscillating reactor of at least 4 h. No significant decrease in red or white blood cell count, platelet count, or hematocrit, and clinically acceptable levels of plasma hemoglobin and activated complement were observed with 2 h (20 passes) of in vitro recirculation of human blood through the reactor. High, stable efficacy, operational stability, and excellent biocompatibility are attributed to secondary flow induced liquid-particle mixing within the oscillating reactor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8434821     DOI: 10.1007/bf02368165

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  18 in total

1.  "Normal" values in hemorrheology.

Authors:  E Ernst; J Eisenberg; A Matrai
Journal:  Haematologica       Date:  1986 May-Jun       Impact factor: 9.941

2.  Specific hemoperfusion through agarose acrobeads.

Authors:  S Margel; L Marcus
Journal:  Appl Biochem Biotechnol       Date:  1986-02       Impact factor: 2.926

3.  Ex vivo model of an immobilized-enzyme reactor.

Authors:  H Bernstein; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  Prolonged use of a membrane oxygenator in air-breathing and hypoxic lambs. I. Venovenous bypass.

Authors:  E L Hanson; R H Bartlett; N E Burns; M C Shults; E J LaCava; H Polet; P A Drinker
Journal:  Surgery       Date:  1973-02       Impact factor: 3.982

5.  The influence of bond chemistry on immobilized enzyme systems for ex vivo use.

Authors:  A R Comfort; C J Mullon; R Langer
Journal:  Biotechnol Bioeng       Date:  1988-08-05       Impact factor: 4.530

6.  An enzymatic system for removing heparin in extracorporeal therapy.

Authors:  R Langer; R J Linhardt; S Hoffberg; A K Larsen; C L Cooney; D Tapper; M Klein
Journal:  Science       Date:  1982-07-16       Impact factor: 47.728

7.  Kinetics of immobilized heparinase in human blood.

Authors:  L E Freed; G V Vunjak-Novakovic; H Bernstein; C L Cooney; R Langer
Journal:  Ann Biomed Eng       Date:  1993       Impact factor: 3.934

Review 8.  Protamine: a review of its toxicity.

Authors:  J C Horrow
Journal:  Anesth Analg       Date:  1985-03       Impact factor: 5.108

9.  Heparinase production by Flavobacterium heparinum.

Authors:  P M Galliher; C L Cooney; R Langer; R J Linhardt
Journal:  Appl Environ Microbiol       Date:  1981-02       Impact factor: 4.792

10.  Purification and characterization of heparinase from Flavobacterium heparinum.

Authors:  V C Yang; R J Linhardt; H Bernstein; C L Cooney; R Langer
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

View more
  3 in total

1.  Mini and customized low-cost bioreactors for optimized high-throughput generation of tissue organoids.

Authors:  Michael A Phelan; Peter I Lelkes; Anand Swaroop
Journal:  Stem Cell Investig       Date:  2018-10-10

2.  Kinetics of immobilized heparinase in human blood.

Authors:  L E Freed; G V Vunjak-Novakovic; H Bernstein; C L Cooney; R Langer
Journal:  Ann Biomed Eng       Date:  1993       Impact factor: 3.934

3.  Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum.

Authors:  S Ernst; G Venkataraman; S Winkler; R Godavarti; R Langer; C L Cooney; R Sasisekharan
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.